Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067351 · ClinicalTrials.gov registry record · Phase 2
Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT02067351: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT02067351 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02067351, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, little is known about the feasibility and effect of MBIs administered during the interval of time of chemotherapy, on QOL and stress. The investigators are planning a MBI intervention study developed specifically for breast cancer survivors receiving chemotherapy (usually 4-5 months) at the investigators institution, for at least 8 sessions combined with at least 8 weeks of home-practice, in 25 women receiving chemotherapy for breast cancer.
Interventions
- BEHAVIORAL Mindfulness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02067351
The ClinicalTrials.gov registry entry for NCT02067351 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness is the first listed.
NCT02067351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02067351 about?
NCT02067351 is a clinical study titled "Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy". There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, l...
What is the current status of trial NCT02067351?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2014-04. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02067351?
The interventions under investigation include: Mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT02067351?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.